1 / 5

Industrial Outlook of Companion Diagnostics Market

The companion diagnostics (CDx) market is projected to grow at a CAGR of 13.14% to reach US$8.974 billion by 2024, from US$4.278 billion in 2018. The growing prevalence of chronic disorders and the improving regulatory framework for supporting drug-diagnostic co-development models are driving the growth of the global companion diagnostics market.

Download Presentation

Industrial Outlook of Companion Diagnostics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Industrial Outlook of Companion Diagnostics Market by Knowledge Sourcing Intelligence Introduction The companion diagnostics (CDx) market is projected to grow at a CAGR of 13.14% to reach US$8.974 billion by 2024, from US$4.278 billion in 2018. A companion diagnostic is a medical device, often an in vitro device (IVD), which provides information that is essential for the safe and effective use of a corresponding drug or biological product (source: FDA). The growing prevalence of chronic disorders and the improving regulatory framework for supporting drug-diagnostic co-development models are driving the growth of the global companion diagnostics (CDx) market. The advent of precision medicine and precision medicine diagnostics improving the quality of a patient’s life will further fuel the growth of the global companion diagnostics market in the forecast period and beyond.

  2. Major players in the companion diagnostics market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the companion diagnostics market. For More Information Visit Here: Market Research Reports Segments and Table Content: Table of Content 1. INTRODUCTION 1.1. Market Overview 1.2. Market Definition 1.3. Scope of the Study 1.4. Currency 1.5. Assumptions 1.6. Base, and Forecast Years Timeline  2. RESEARCH METHODOLOGY 2.1. Research Design 2.2. Secondary Sources   3. EXECUTIVE SUMMARY 4. MARKET DYNAMICS 4.1. Market Segmentation 4.2. Market Drivers 4.3. Market Restraints 4.4. Market Opportunities 4.5. Porter’s Five Forces Analysis 4.5.1. Bargaining Power of Suppliers 4.5.2. Bargaining Power of Buyers 4.5.3. Threat of New Entrants 4.5.4. Threat of Substitutes 4.5.5. Competitive Rivalry in the Industry 4.6. Life Cycle Analysis - Regional Snapshot 4.7. Market Attractiveness  5. COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY 5.1. Polymerase Chain Reaction (PCR) 5.2. Immunohistochemistry (IHC) 5.3. In-situ Hybridization (ISH) 5.4. Next-Generation Sequencing (NGS) 

  3. 6. COMPANION DIAGNOSTICS MARKET BY INDICATION 6.1. Lung Cancer 6.2. Breast Cancer 6.3. Colorectal Cancer 6.4. Other Oncology and non-oncology diseases  7. COMPANION DIAGNOSTICS MARKET BY GEOGRAPHY 7.1. North America 7.1.1. United States 7.1.2. Canada 7.1.3. Mexico 7.2. South America 7.2.1. Brazil 7.2.2. Argentina 7.2.3. Others 7.3. Europe 7.3.1. United Kingdom 7.3.2. Germany 7.3.3. France 7.3.4. Italy 7.3.5. Others 7.4. Middle East and Africa 7.4.1. Saudi Arabia 7.4.2. Israel 7.4.3. Others 7.5. Asia Pacific 7.5.1. China 7.5.2. Japan 7.5.3. India 7.5.4. South Korea 7.5.5. Others  8. COMPETITIVE INTELLIGENCE 8.1. Competitive Benchmarking and Analysis 8.2. Recent Investments and Deals 8.3. Strategies of Key Players  9. COMPANY PROFILES 9.1. Abbott Laboratories 9.2. Agilent Technologies, Inc. 9.3. ARUP Laboratories 9.4. F. Hoffmann-La Roche Ltd 9.5. Illumina, Inc. 9.6. Invivoscribe 9.7. Myriad Genetics, Inc. 9.8. QIAGEN 9.9. Thermo Fisher Scientific Inc. 

  4. TO ORDER OR REQUEST FOR A SAMPLE: Product: Companion Diagnostics Market - Industry Trends, Opportunities and Forecasts to 2024 Link: https://www.knowledge-sourcing.com/report/companion-diagnostics-cdx-market Price: US$3,950 – Single User License US$4,550 – Multi User License US$6,950– Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Contact us: Address: Suite 406, BSI Business Park, H-140, Sector 63 Noida, U.P. - 201301 India Email: info@knowledge-sourcing.com Phone: +1-850-250-1698 Follow us: FaceBook LinkedIn Twitter

  5. Thank You

More Related